Rhythm Pharmaceuticals, Inc. (RYTM)

Nasdaq · Healthcare · Biotechnology
$112.36-3.80%As of 2026-11-22 · USD
Last session low $112.00Last session high $117.00
52-week low $74.5052-week high $122.20
Market cap
$7.79B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)59.4In the neutral range (30 to 70)
MACD (12, 26, 9)5.87Above its signal line (4.90); histogram 0.97
Bollinger %B (20, 2)66%Inside the bands (83.71 to 126.91)
SMA 20105.31Price is 6.7% above
SMA 5098.12Price is 14.5% above
SMA 20097.45Price is 15.3% above
ATR (20)4.99% of priceAverage true range per day
52-week position79%In the upper part of the 74.50 to 122.20 range

About Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally.

Insider filings, 90 daysNo purchases and 4 sales (about $18.4M).
Latest fiscal yearEnded 2025-12-31: revenue of $189.76M and an operating margin of -101.2%.

More in Biotechnology